BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 28629473)

  • 1. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial.
    Lyttle MD; Gamble C; Messahel S; Hickey H; Iyer A; Woolfall K; Humphreys A; Bacon NEA; Roper L; Babl FE; Dalziel SR; Ryan M; Appleton RE;
    Trials; 2017 Jun; 18(1):283. PubMed ID: 28629473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Köle MT; Sager SG; Zeynel H; Çağ Y; Akın Y
    Childs Nerv Syst; 2022 Jul; 38(7):1357-1364. PubMed ID: 35501510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
    Zaccara G; Giorgi FS; Amantini A; Giannasi G; Campostrini R; Giovannelli F; Paganini M; Nazerian P;
    Acta Neurol Scand; 2018 Jun; 137(6):618-622. PubMed ID: 29624640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
    Navarro V; Dagron C; Elie C; Lamhaut L; Demeret S; Urien S; An K; Bolgert F; Tréluyer JM; Baulac M; Carli P;
    Lancet Neurol; 2016 Jan; 15(1):47-55. PubMed ID: 26627366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
    Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
    Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
    Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
    Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
    Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
    Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R; Güzel O; Ceylan G; Yılmaz Ü; Ağın H
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Phenytoin, Valproate and Levetiracetam in Pediatric Convulsive Status Epilepticus: A Randomized Double-blind Controlled Clinical Trial.
    Vignesh V; Rameshkumar R; Mahadevan S
    Indian Pediatr; 2020 Mar; 57(3):222-227. PubMed ID: 32198861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial.
    Nakamura K; Marushima A; Takahashi Y; Kimura A; Asami M; Egawa S; Kaneko J; Kondo Y; Yonekawa C; Hoshiyama E; Yamada T; Maruo K; Inoue Y;
    Trials; 2021 May; 22(1):317. PubMed ID: 33934714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
    Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
    CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.